1. Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. (October 2022) Authors: Harnden, A.; Huckvale, R.; Cheung, K.M.; Davis, O.; Pierrat, O.; Talbot, R.; Box, G.; Bright, M.; Akpinar, A.; Miller, D.; Hayes, A.; Gunnell, E.; Le Bihan, Y.V.; Burke, R.; Kirkin, V.; Van Montfort, R.; Raynaud, F.; Rossanese, O.; Bellenie, B.; Hoelder, S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Creating a novel approach to discourse treatment through coproduction with people with aphasia and speech and language therapists. Issue 10 (3rd October 2022) Authors: Cruice, M.; Aujla, S.; Bannister, J.; Botting, N.; Boyle, M.; Charles, N.; Dhaliwal, V.; Grobler, S.; Hersh, D.; Marshall, J.; Morris, S.; Pritchard, M.; Scarth, L.; Talbot, R.; Dipper, L. Journal: Aphasiology Issue: Volume 36:Issue 10(2022) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Major obstetric haemorrhage of 2000 ml or greater: a clinical audit. (17th November 2018) Authors: O'Sullivan, J.; Mansfield, R.; Talbot, R.; Cairns, A. E. Journal: Journal of obstetrics and gynaecology Issue: Volume 38:Number 8(2018) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗